These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31823876)

  • 41. [Depression and neuroplasticity. Interaction of nervous, endocrine and immune systems].
    Cassano P; Argibay P
    Medicina (B Aires); 2010; 70(2):185-93. PubMed ID: 20447905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FAS -670A>G genetic polymorphism Is associated with Treatment Resistant Depression.
    Santos M; Carvalho S; Lima L; Mota-Pereira J; Pimentel P; Maia D; Correia D; Gomes S; Cruz A; Medeiros R
    J Affect Disord; 2015 Oct; 185():164-9. PubMed ID: 26186532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of longer-term outcome of treatment-resistant depression in tertiary care.
    Fekadu A; Rane LJ; Wooderson SC; Markopoulou K; Poon L; Cleare AJ
    Br J Psychiatry; 2012 Nov; 201(5):369-75. PubMed ID: 22955008
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin.
    Lietzau G; Davidsson W; Östenson CG; Chiazza F; Nathanson D; Pintana H; Skogsberg J; Klein T; Nyström T; Darsalia V; Patrone C
    Acta Neuropathol Commun; 2018 Feb; 6(1):14. PubMed ID: 29471869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pharmacological treatment of resistant depression].
    Bertera HJ
    Vertex; 2005; 16(64):460-8. PubMed ID: 16314901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resistant Against De-depression: LTD-Like Plasticity in the Human Motor Cortex Induced by Spaced cTBS.
    Goldsworthy MR; Müller-Dahlhaus F; Ridding MC; Ziemann U
    Cereb Cortex; 2015 Jul; 25(7):1724-34. PubMed ID: 24488942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The endocannabinoid/endovanilloid system and depression.
    Smaga I; Bystrowska B; Gawliński D; Przegaliński E; Filip M
    Curr Neuropharmacol; 2014 Sep; 12(5):462-74. PubMed ID: 25426013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ["Atypical" antidepressive mechanisms: glutamatergic modulation and neuroplasticity in case of tianeptine].
    András S
    Neuropsychopharmacol Hung; 2008 Dec; 10(5):305-13. PubMed ID: 19419016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopamine D(3) receptor as a new pharmacological target for the treatment of depression.
    Leggio GM; Salomone S; Bucolo C; Platania C; Micale V; Caraci F; Drago F
    Eur J Pharmacol; 2013 Nov; 719(1-3):25-33. PubMed ID: 23872400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic Challenges of Post-traumatic Stress Disorder: Focus on the Dopaminergic System.
    Torrisi SA; Leggio GM; Drago F; Salomone S
    Front Pharmacol; 2019; 10():404. PubMed ID: 31057408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety in pharmacological enhancement of stroke rehabilitation.
    Engelter ST
    Eur J Phys Rehabil Med; 2013 Apr; 49(2):261-7. PubMed ID: 23438654
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypoxic conditioning and the central nervous system: A new therapeutic opportunity for brain and spinal cord injuries?
    Baillieul S; Chacaroun S; Doutreleau S; Detante O; Pépin JL; Verges S
    Exp Biol Med (Maywood); 2017 Jun; 242(11):1198-1206. PubMed ID: 28585890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological interventions in autism: theoretical and practical issues.
    Volkmar FR
    J Clin Child Psychol; 2001 Mar; 30(1):80-7. PubMed ID: 11294081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The pharmacological treatment of tricyclic-resistant depression: review and management guidelines.
    Mitchell P
    Aust N Z J Psychiatry; 1987 Dec; 21(4):442-51. PubMed ID: 3329512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroplasticity: an appreciation from synapse to system.
    Gillick BT; Zirpel L
    Arch Phys Med Rehabil; 2012 Oct; 93(10):1846-55. PubMed ID: 22613094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Excessive endoplasmic reticulum stress and decreased neuroplasticity-associated proteins in prefrontal cortex of obese rats and the regulatory effects of aerobic exercise.
    Li F; Liu BB; Cai M; Li JJ; Lou SJ
    Brain Res Bull; 2018 Jun; 140():52-59. PubMed ID: 29630996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amygdalar expression of proteins associated with neuroplasticity in major depression and suicide.
    Maheu ME; Davoli MA; Turecki G; Mechawar N
    J Psychiatr Res; 2013 Mar; 47(3):384-90. PubMed ID: 23260340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Testosterone has antidepressant-like efficacy and facilitates imipramine-induced neuroplasticity in male rats exposed to chronic unpredictable stress.
    Wainwright SR; Workman JL; Tehrani A; Hamson DK; Chow C; Lieblich SE; Galea LA
    Horm Behav; 2016 Mar; 79():58-69. PubMed ID: 26774465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The impact of electrophysiology of central dopaminergic neurons and the depression-state induced by chronic neuropathic pain].
    Fu B; Weng XC; Wang J; Huang T; Wang B; Lin SD; Liu SJ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2016 May; 32(5):403-407. PubMed ID: 29931842
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopaminergic agents and stimulants as antidepressant augmentation strategies.
    Nierenberg AA; Dougherty D; Rosenbaum JF
    J Clin Psychiatry; 1998; 59 Suppl 5():60-3; discussion 64. PubMed ID: 9635549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.